Cargando…

EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

PURPOSE: To evaluate the outcome of an exit strategy in a treat-and-extend regimen for neovascular age-related macular degeneration. METHODS: Five hundred and ninety-eight eyes of 488 patients with neovascular age-related macular degeneration receiving intravitreal anti–vascular endothelial growth f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arendt, Petra, Yu, Siqing, Munk, Marion R., Ebneter, Andreas, Wolf, Sebastian, Zinkernagel, Martin S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2019
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325772/ https://www.ncbi.nlm.nih.gov/pubmed/29135888 http://dx.doi.org/10.1097/IAE.0000000000001923

Ejemplares similares

Aflibercept for age-related macular degeneration: 4-year outcomes of a ‘treat-and-extend’ regimen with exit-strategy
por: Jaggi, Damian, et al.
Publicado: (2022)

Functional and anatomical outcome of eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab following an exit strategy regimen
por: Menke, Marcel N, et al.
Publicado: (2014)

Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab
por: Ebneter, Andreas, et al.
Publicado: (2016)

Cataract significantly influences quantitative measurements on swept-source optical coherence tomography angiography imaging
por: Yu, Siqing, et al.
Publicado: (2018)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
por: Kikushima, Wataru, et al.
Publicado: (2023)

Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration
por: Ebneter, Andreas, et al.
Publicado: (2020)

Expert-level Automated Biomarker Identification in Optical Coherence Tomography Scans
por: Kurmann, Thomas, et al.
Publicado: (2019)

Neuroprotection with rasagiline in patients with macula-off retinal detachment: A randomized controlled pilot study
por: Yu, Siqing, et al.
Publicado: (2020)

AUTOMATED RETINAL LAYER SEGMENTATION AND THEIR THICKNESS PROFILES IN HEALTHY SUBJECTS: A Comparison of 55° Wide-field and Conventional 30° Spectral Domain-Optical Coherence Tomography
por: Giannakaki-Zimmermann, Helena, et al.
Publicado: (2020)

Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy
por: Kinoshita, Takamasa, et al.
Publicado: (2021)

Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
por: Menke, Marcel N., et al.
Publicado: (2016)

Recurrence of neovascular age-related macular degeneration after cessation of treat and extend regimen
por: Hirata, Yuki, et al.
Publicado: (2022)

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR: A Randomized Controlled Trial
por: Ohji, Masahito, et al.
Publicado: (2020)

Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)

Age-Related Macular Degeneration and Diabetic Retinopathy
por: Ebneter, Andreas, et al.
Publicado: (2022)

OCT-angiography: A qualitative and quantitative comparison of 4 OCT-A devices
por: Munk, Marion R., et al.
Publicado: (2017)

LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration
por: Burton, Ben, et al.
Publicado: (2023)

Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degeneration
por: Giannakaki-Zimmermann, Helena, et al.
Publicado: (2017)

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
por: Ohji, Masahito, et al.
Publicado: (2021)

Early Signs of Exudative Age-Related Macular Degeneration in Asians
por: Sasaki, Mariko, et al.
Publicado: (2014)

Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Unusual visual loss in a patient with exudative macular degeneration
por: Peng, Enoch T., et al.
Publicado: (2022)

EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical Trial
por: Mitchell, Paul, et al.
Publicado: (2021)

Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
por: Ohji, Masahito, et al.
Publicado: (2022)

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
por: Motozawa, Naohiro, et al.
Publicado: (2019)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Gemenetzi, Maria, et al.
Publicado: (2017)

Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration
por: Quist, S. W., et al.
Publicado: (2021)

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan
por: Cheng, Cheng-Kuo, et al.
Publicado: (2022)

Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration
por: Morken, Tora Sund, et al.
Publicado: (2022)

Repeatability of Wide-field Optical Coherence Tomography Angiography in Normal Retina
por: Eastline, Michael, et al.
Publicado: (2019)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION
por: Takasago, Yukari, et al.
Publicado: (2019)

The Past, Present, and Future of Exudative Age-Related Macular Degeneration Treatment
por: Barak, Yoreh, et al.
Publicado: (2012)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Real-Life Data of Patients with Exudative Age-Related Macular Degeneration
por: Togac, Mesut, et al.
Publicado: (2021)

One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2022)

Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2023)

Clinical outcomes of 1 + PRN and 3 + Q3M regimens of intravitreal conbercept injection for exudative age-related macular degeneration
por: Gao, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_57g85bvbiak0bb413lpv2islag